PBM Execs Stay On Message Amid Growing US Congressional Frustration At Hearing

 
• By Cathy Kelly

The House Oversight Committee held its third hearing on pharmacy benefit manager reforms in 14 months, but could not elicit an admission from executives that they are responsible for increasing drug prices.

House Oversight Committee PBM Hearing
PBM Executives Faced House Oversight Committee on 23 July. • Source: Screenshot of House Broadcast

More from Market Access

More from Pink Sheet